Short answer
Corteva (CTVA) filed an 8-K current report with the SEC on November 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.3 (Exhibit EX-99.3), Item EX-99.2 (Exhibit EX-99.2). Corteva announced consolidated results for the quarter ended September 30, 2026.
Corteva 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Corteva announced consolidated results for the quarter ended September 30, 2026
- Press release and financial statement schedules filed as Exhibits 99.1 and 99.2, providing the substantive financial details
Item EX-99.1 · Exhibit EX-99.1
- Q3 net sales $1.591B, down 9%, with adjusted Operating EBITDA $222M, down 17%, signaling substantial market pressure
- YTD adjusted Operating EPS $0.76, up 49%, despite GAAP EPS $0.16, down 68%, highlighting significant non-GAAP adjustments
- Brazil weakness drove Latin America organic sales down 31% in Q3, with volume down 24% amid inventory and farmer liquidity constraints
- FY 2026 guidance reduced to adjusted Operating EBITDA $1.1B-$1.125B and adjusted Operating EPS $0.76-$0.80
- Board authorized Corteva’s first common dividend following the Seed business spin, creating a new shareholder-return mechanism
Item EX-99.2 · Exhibit EX-99.2
- Pro forma Q3 net sales $1,591M, down 9% year over year, with organic sales down 9% and Latin America down 31%
- Q3 adjusted operating EBITDA $222M, margin 14.0%, versus $268M and 15.4% in 2025
- Q3 pro forma net loss $56M, or $(0.08) per share, versus $58M profit and $0.09 per share
- Nine-month adjusted operating EBITDA $943M, up from $937M, while adjusted EPS improved to $0.76 from $0.51
- September 30 pro forma balance sheet: $1,798M cash, $1,004M total debt, and $12,120M total equity
Item EX-99.3 · Exhibit EX-99.3
- Spin-off completed October 1, 2026, creating New Corteva as a standalone Crop Protection company and Vylor as the Seed business
- Pro forma debt reduced by $2.211 billion, including $1.439 billion of exchanged notes and $783 million of short-term borrowings repaid
- Standalone balance sheet shows $1.798 billion cash, $944 million long-term debt and $11.881 billion New Corteva equity
- Nine-month 2026 pro forma sales $5.357 billion and net income $105 million, versus $5.419 billion and $340 million in 2025
- Autonomous-company adjustments reduced nine-month 2026 sales by $179 million and income by $114 million, highlighting separation-related earnings pressure
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Corteva 8-K filings
Get the next CTVA 8-K as it lands
Follow CTVA for push alerts, or ask the research agent what this filing means.